why choose us

First received: January 25, 2023

Clinical Trial: Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Breast Cancer
Lymphoma, Large B-Cell, Diffuse
Cardiotoxicity
Left Ventricular Dysfunc

Study Type: Interventional


Official Title: Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines (CONTROL Trial)

Brief Summary: As the cancer-related prognosis improves thanks to recent advances in cancer-targeted therapies, the prognostic burden of chemotherapy-related complications - including cardiotoxicity - is increasingly recognised. So far, the evidence supporting pharmacological preventive strategies in cardio-oncology has been inconsistent and conflicting, and there is a clear need for well-designed trials with novel interventions. In this study, by using cardiac magnetic resonance, the investigators want to assess if a commonly…

Read more